Previous 10 | Next 10 |
Acushnet Holdings Corp. (GOLF) is expected to report $0.54 for Q3 2023 Paramount Global (PARA) is expected to report $0.09 for Q3 2023 Curis Inc. (CRIS) is expected to report $-2.32 for Q3 2023 Quanta Services Inc. (PWR) is expected to report $1.99 for Q3 2023 GRI Bio Inc. (GRI) i...
DarioHealth Reports Third Quarter 2023 Financial and Operating Results PR Newswire Third quarter total revenue of $3.52 million compared to $6.6 million in the third quarter of 2022, impacted mainly by lower commercial strategic partners revenues in the quarter of ...
DarioHealth Corp. (DRIO) is expected to report $-0.5 for Q3 2023
2023-11-01 13:50:36 ET More on DarioHealth DarioHealth Disappoints, But A Better Future Is Ahead DarioHealth Corp. (DRIO) Q2 2023 Earnings Call Transcript DarioHealth GAAP EPS of -$0.58 misses by $0.06, revenue of $6.15M beats by $0.14M Dario expands partners...
Dario Launches Apple iPhone 15 Accessible Smart Blood Glucose Meter PR Newswire New connectivity expands Dario's advantage with consumer accessibility NEW YORK , Nov. 1, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company")...
DarioHealth (NASDAQ: DRIO) , a leader in the global digital health market, will be releasing its financial results for Q3 2023 on Nov. 2, 2023, before the market opens. In addition, the company also announced plans to host a conference call and webcast the same day at 8:30 a.m. ET. According to t...
DarioHealth to Report Third Quarter 2023 Results on Thursday, November 2nd PR Newswire Company to host conference call and webcast at 8:30am ET NEW YORK , Oct. 30, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital healt...
DarioHealth (NASDAQ: DRIO) , a leader in the global digital health market, is reporting on award-winning new research conducted by Sanofi U.S. that indicates the company’s ability to reduce costs through lower utilization of expensive healthcare resources. Sanofi US reported the research a...
New Research Shows 36% Reduction in 30-Day Hospital Readmission Rate for Dario Users with Type 2 Diabetes PR Newswire New research demonstrates Dario's ability to reduce costs through lower utilization of expensive healthcare resources, and the winning of a prestigious gold ri...
2023-10-13 15:00:54 ET Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar ...
News, Short Squeeze, Breakout and More Instantly...
DarioHealth (NASDAQ: DRIO) , a leader in the global digital health market, is planning to release its financial results for the second quarter 2024, covering the period ended June 30, 2024. According to the announcement, the company will release the report on Aug. 8, 2024, before the market opens...
DarioHealth to Report Second Quarter 2024 Results on Thursday, August 8th PR Newswire Company to host conference call and webcast at 8:30am ET NEW YORK , July 30, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital th...
DarioHealth (NASDAQ: DRIO) , a leader in the global digital health market, today announced a new contract with a national employer to provide its cardiometabolic solution with integrated support for GLP-1s to employees beginning in the third quarter of 2024. “The challenges associated with...